We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

By LabMedica International staff writers
Posted on 22 Jul 2025

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense. More...

These autoantibodies can go undetected for extended periods, making diagnosis difficult and delaying critical treatment. Traditional testing methods can be slow, expensive, and insensitive to trace levels of harmful antibodies, especially in the early stages of illness. Now, researchers have developed a rapid, highly sensitive paper-based test that enables one-step detection of these autoantibodies in under 10 minutes.

The paper-based diagnostic device called the 3D-osPAD (3D origami signal-amplified paper-based analytical device) has been developed by scientists at National Taiwan University (Taipei, Taiwan) and uses a folded 3D paper structure combined with gold nanoparticle signal amplification to enhance detection. All necessary reagents are preloaded within layered compartments, which allows the assay to initiate automatically once a small drop of diluted blood serum is added. The design enables a one-step, streamlined process that does not require expensive laboratory equipment or specialized training, making it accessible for both hospital and remote clinical settings. This technological innovation significantly improves test sensitivity achieving a tenfold increase over conventional detection methods while delivering results in just 10 minutes.

In the study published in Biosensors and Bioelectronics, the 3D-osPAD was clinically validated and demonstrated 100% sensitivity and specificity in accurately identifying patients with adult-onset immunodeficiency caused by anti-IFN-γ autoantibodies. In addition to its clinical accuracy, the portable and user-friendly design of the test supports applications in rapid diagnosis, treatment planning, and recovery monitoring. The researchers plan to further develop similar user-friendly and highly sensitive analytical tools for on-site diagnostics, especially in resource-limited environments.

Related Links:
National Taiwan University


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.